论文部分内容阅读
子宫颈癌是妇女最常见的恶性肿瘤之一,目前已经在女性恶性肿瘤中排名第二,并呈年轻化趋势。据统计每年有近50万新发病例,而总体5年生存率在52%左右。子宫颈癌的手术治疗、放疗和化疗及新的治疗方式,在一定程度上提高了患者生存率,但治疗效果仍不能令人满意,至上世纪70年代中期,世界范围内宫颈癌总的5年生存率达到40%～50%,Ⅰ期为70%～80%,Ⅱ期55%～60%,Ⅲ期30%～40%,Ⅳ期6%～10%,迄今仍基本维持在这一水平 2。多年来,学者们一直在致力于寻求新的微创、副反应小、可以根治肿瘤的方法,随着分
Cervical cancer is one of the most common malignant tumors in women and is currently the second most frequently reported female malignant tumor with a younger trend. According to statistics, there are nearly 500,000 new cases each year, while the overall 5-year survival rate is about 52%. Surgical treatment of cervical cancer, radiotherapy and chemotherapy and new treatment methods, to some extent, improve patient survival, but the treatment effect is still not satisfactory, to the mid-70s of last century, the world’s total of 5 years of cervical cancer Survival rate of 40% to 50%, stage Ⅰ 70% to 80%, stage Ⅱ 55% to 60%, stage Ⅲ 30% to 40%, stage Ⅳ 6% to 10%, so far still remained at this level 2. Over the years, scholars have been working to find new minimally invasive, side effects, can cure cancer, with the sub